Meister G C, D'Angelo R, Owen M, Nelson K E, Gaver R
Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Anesth Analg. 2000 Mar;90(3):632-7. doi: 10.1097/00000539-200003000-00024.
We previously found that the extent of an epidural motor block produced by 0.125% ropivacaine was clinically indistinguishable from 0.125% bupivacaine in laboring patients. By adding fentanyl to the 0. 125% ropivacaine and bupivacaine solutions in an attempt to reduce hourly local anesthetic requirements, we hypothesized that differences in motor block produced by the two drugs may become apparent. Fifty laboring women were randomized to receive either 0. 125% ropivacaine with fentanyl 2 microg/mL or an equivalent concentration of bupivacaine/fentanyl using patient-controlled epidural analgesia (PCEA) with settings of: 6-mL/hr basal rate, 5-mL bolus, 10-min lockout, 30-mL/h dose limit. Analgesia, local anesthetic use, motor block, patient satisfaction, and side effects were assessed until the time of delivery. No differences in verbal pain scores, local anesthetic use, patient satisfaction, or side effects between groups were observed; however, patients administered ropivacaine/fentanyl developed significantly less motor block than patients administered bupivacaine/fentanyl. Ropivacaine 0.125% with fentanyl 2 microg/mL produces similar labor analgesia with significantly less motor block than an equivalent concentration of bupivacaine/fentanyl. Whether this statistical reduction in motor block improves clinical outcome or is applicable to anesthesia practices which do not use the PCEA technique remains to be determined.
By using a patient-controlled epidural analgesia technique, ropivacaine 0.125% with fentanyl 2 microg/mL produces similar analgesia with significantly less motor block than a similar concentration of bupivacaine with fentanyl during labor. Whether this statistical reduction in motor block improves clinical outcome or is applicable to anesthesia practices which do not use the patient-controlled epidural analgesia technique remains to be determined.
我们之前发现,在分娩患者中,0.125%罗哌卡因产生的硬膜外运动阻滞程度在临床上与0.125%布比卡因无法区分。通过在0.125%罗哌卡因和布比卡因溶液中添加芬太尼以试图减少每小时局部麻醉药需求量,我们推测这两种药物产生的运动阻滞差异可能会变得明显。50名分娩妇女被随机分为两组,分别接受含2μg/mL芬太尼的0.125%罗哌卡因或同等浓度的布比卡因/芬太尼,采用患者自控硬膜外镇痛(PCEA),设置为:基础输注速率6mL/小时,单次推注量5mL,锁定时间10分钟,每小时剂量限制30mL。在分娩前评估镇痛效果、局部麻醉药使用情况、运动阻滞、患者满意度和副作用。两组之间在言语疼痛评分、局部麻醉药使用、患者满意度或副作用方面未观察到差异;然而,接受罗哌卡因/芬太尼的患者产生的运动阻滞明显少于接受布比卡因/芬太尼的患者。含2μg/mL芬太尼的0.125%罗哌卡因产生的分娩镇痛效果相似,但运动阻滞明显少于同等浓度的布比卡因/芬太尼。这种运动阻滞的统计学降低是否能改善临床结局或是否适用于不使用PCEA技术的麻醉实践仍有待确定。
通过使用患者自控硬膜外镇痛技术,含2μg/mL芬太尼的0.125%罗哌卡因在分娩期间产生的镇痛效果相似,但运动阻滞明显少于含芬太尼的同等浓度布比卡因。这种运动阻滞的统计学降低是否能改善临床结局或是否适用于不使用患者自控硬膜外镇痛技术的麻醉实践仍有待确定。